NSCLC Liquid Biopsies and Exhaled VOC
Recruiting · NCT06707519 · Observational (researchers observe without assigning treatment) · Lead sponsor: St. Joseph's Healthcare Hamilton
View the official record on ClinicalTrials.gov →What this trial is about
The objective of the study is to determine the feasibility of recruiting participants and using sputum, Bronchoalveolar lavage (BAL) and exhaled Volatile Organic Compounds (VOC) in addition to blood, as biological samples for detecting mutations in extracted cell-free DNA in non-small cell lung cancer (NSCLC) patients, before and after surgery, and any recurrence within a 24-month postoperative follow-up period. This is a pilot feasibility study, proposed as a 24-month prospective, single-center, non-interventional, observational trial with NSCLC-adenocarcinoma patients indicated for resection surgery with curative intent.
Who can take part
Inclusion criteria
- Patient must be at least 18 years of age
- Patient must be able to provide consent
- Patients undergoing surgical resection with curative intent for non-small cell lung cancer at St. Joseph's Healthcare Hamilton and Firestone Institute for Respiratory Health.
Exclusion criteria
- Resection done with non-curative intent or metastatic disease
- other malignancies
- Patients with previously treated malignancy less than 5 years prior to current resection (not including skin cancer).
Where it is running
1 location listed.
- St. Joseph's Healthcare Hamilton - Hamilton, Ontario, Canada